FINNENCE ▪ THE WIRE FILE
THE WIRE · № 69670
News▼ Bearish
AVBP SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving ArriVent BioPharma

KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 18:20 UTC
LAST UPDATE2026-10-07 18:20 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A Phase 3 miss and 56.7% premarket drop plus securities investigation raise single-name biotech risk and legal overhang.
Clinical miss plus investigation pressures the stock
CATALYST TO WATCH
Details of the securities investigation
MAIN RISK
Further downside if claims gain traction
FULL DISPATCH
AVBP was down 56.7% before the opening bell and traded as low as $12.09 after ArriVent disclosed that its Phase 3 FURVENT trial of firmonertinib missed its primary endpoint. An investigation into potential securities law violations is underway. NEW YORK, Oct. 7, 2026 /PRNewswire/ --...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
AFFECTEDSPDR Biotech ETF · XBI
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Cold Plasma in Healthcare Market to Reach USD 6,634 Million by 20322026-10-07 18:32 UTC
Cold Plasma in Healthcare Market to Reach USD 6,634 Million by 20322026-10-07 18:32 UTC
→CORRELATIONshares Healthcare
Wally Raises $25 Million to Scale Nation's Fastest-Growing Oral Care Membership with Unlimited Cleanings & Diagnostics2026-10-07 19:35 UTC
Wally Raises $25 Million to Scale Nation's Fastest-Growing Oral Care Membership with Unlimited Cleanings & Diagnostics2026-10-07 19:35 UTC
→CORRELATIONshares Healthcare
Medical device maker Centinel Spine discloses revenue rise in US IPO filing2026-10-07 21:13 UTC
Medical device maker Centinel Spine discloses revenue rise in US IPO filing2026-10-07 21:13 UTC
→CORRELATIONshares Healthcare
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.2026-10-07 21:31 UTC
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.2026-10-07 21:31 UTC
→CORRELATIONshares Healthcare
Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder2026-10-07 21:51 UTC
Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder2026-10-07 21:51 UTC
→CORRELATIONshares Healthcare
CNTL IPO News - Spinal implant developer Centinel Spine files for a $100 million IPO2026-10-07 21:24 UTC
CNTL IPO News - Spinal implant developer Centinel Spine files for a $100 million IPO2026-10-07 21:24 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.